瑞麗醫美國際控股有限公司 02135Stock Information

Stock Information · Old Rules
// Company Overview //
Stock Name瑞麗醫美國際控股有限公司
Stock Code02135
Company Full Name瑞麗醫美國際控股有限公司
Industry醫療保健
Principal Activities主要在中國從事提供醫療美容服務及諮詢服務。
Listing Date2020-12-28
Listing Rules EraOld Rules
Listing Rules ChapterNo data
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國浙江省杭州市下城區中山北路290號民航大廈3–5樓
Business Address (Hong Kong)No data
Place of IncorporationNo data
Listing MethodNo data
Listing BoardMain Board
Websitehttp://www.raily.com
Share Registrar卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact(852)2980 1333
A-Share/US Dual ListingNo data
// Offering Information //
Prospectus Date2020-12-15
Offer PriceHK$ 0.40 / shares
Total Funds RaisedHK$ 68,500,000
// Valuation & Financials //
Market Cap (at Offer Price)HK$ 0
// First Day Performance
First Day CloseLoading...
First Day OpenHK$ 0.475
First Day Change8.75%
First Day Volume819968000.0
First Day Turnover386834000.0
// Price Chart //
Loading...
// Use of Proceeds
Use of Proceeds1、約28.0%,或19.7百萬港元,將用作翻新所有現有醫療美容機構并擴張杭州瑞麗、瑞麗天鴿及蕪湖瑞麗,以提升能力、更新品牌形象及擴大市場份額; 2、約28.0%,或19.7百萬港元,將用作為上海市新建醫療美容機構的資本支出及初始營運成本提供資金; 3、約15.0%,或10.6百萬港元,將用作中國浙江省醫療美容機構的潛在戰略收購; 4、約11.0%,或7.8百萬港元,將用作購買醫療美容服務設備及醫療消耗品,以完善若干醫療美容診療,擴大醫療美容服務范圍; 5、約8.0%,或5.6百萬港元將用于積極推廣我們的品牌; 6、約10%,或7.0百萬港元,將用作一般營運資金及其他一般公司用途。
// Underwriting Syndicate //
独家保荐人 (1)
创升融资有限公司
整体协调人 (2)
创升证券有限公司 千里硕证券有限公司
联席账簿管理人 (5)
创升证券有限公司 千里硕证券有限公司 交银国际证券有限公司 安信国际证券(香港)有限公司 First Fidelity Capital (International) Limited
联席牵头经办人 (9)
创升证券有限公司 千里硕证券有限公司 交银国际证券有限公司 安信国际证券(香港)有限公司 First Fidelity Capital (International) Limited 麒麟证券有限公司 京基证券集团有限公司 伟禄亚太证券有限公司 太阳国际证券有限公司
// Cornerstone Investors //
#Investor NameInvestment AmountShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 昊海生物科技控股有限公司 20,000,000 HKD 14.60% 6 months 2021-06-28
2 途益香港有限公司 10,000,000 HKD 7.30% 6 months 2021-06-28
// Directors & Management //
Chairman傅海曙
Company Secretary陳愛發
No director data available.
// Major Shareholders //
Major Shareholders & Holdings傅海曙(53.10%);美天下責任(香港)有限公司(6.18%);上海東嫿健康管理合伙企業(有限合伙)(5.37%)
Disclaimer & Risk Warning

Site Nature: This website (cibo.qizai.ai) is an independent technology product showcase platform established by Panda Securities Limited (CE Number: BNC380). This website itself and all content displayed herein do not constitute and are not involved in any regulated activity or licensed service.

Not Investment Advice: The data on this page is automatically extracted from prospectus PDFs by AI and may contain omissions or errors. Some data is supplemented from HKEX New Listing Reports ([HKEX]). All information and data on this page are sourced from prospectuses and related historical documents, are not real-time data, and will not be automatically updated, reflecting historical information at the time of prospectus publication. All content is provided solely for AI tool analysis learning exchange and technical reference purposes, and absolutely does not constitute any investment advice, offer to buy or sell, solicitation, recommendation, or guarantee. The output of this AI analysis tool should not be interpreted as investment opinion.

Decision Responsibility: Users should make investment decisions based on their own independent judgment and consult independent licensed financial advisors when needed. Neither the Company nor this AI analysis tool shall bear any responsibility for any investment decisions made by users based on the information on this page.

Separation from Panda Securities Official Website: The content of this website is strictly distinct from the SFC-regulated licensed services provided by Panda Securities' official website (fafa.hk). No securities trading or account opening or other regulated operations can be conducted through this website.

Panda Securities Limited is a licensed corporation regulated by the Hong Kong SFC (CE Number: BNC380) and a Hong Kong Exchange Participant (Participant ID: 02229). Use of this website constitutes acceptance of this disclaimer.

Cibo — IPO & Market Data Analytics